San Diego, CA – Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, has announced the launch of updated t:slim X2™ insulin pump software featuring integration with Dexcom G7 Continuous Glucose Monitoring (CGM) in the United States. Tandem’s highly rated automated insulin delivery (AID) system* with Control-IQ technology now stands as the sole AID option globally utilizing Dexcom’s latest CGM technology.
The in-warranty t:slim X2 users in the United States, numbering over 300,000, will receive email instructions, enabling them to add the new Dexcom G7 integration feature free of charge through a remote software update. Meanwhile, t:slim X2 pumps pre-loaded with the updated software have commenced shipping to new customers.
The integration with Dexcom G7 opens up new possibilities for t:slim X2 insulin pump users, allowing them to spend more time in a closed loop with minimal wait time between Dexcom G7 CGM sensor sessions. Additionally, users can opt for either a Dexcom G6 or Dexcom G7 CGM sensor, providing more flexibility in diabetes management....READ MORE
The Ministry of Health and Prevention (MoHAP) has surpassed the Diabetes early detection goal, carrying out more than 150,000 screenings nationwide, above the target of 1...
San Diego, CA – Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, has announced the launch of updated t:slim X2™ insulin pump software fea...
A virtual marketplace leading your business into the future
